Anteris Technologies Ltd partners with medtech heavyweights for FDA early feasibility study proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Anteris Technologies boosts funds with $1.49 million R&D refund
It will repay the short-term facility entered into with Mitchell Asset Management for the advance of $1.22 million for its forecasted R&D tax incentive. The claim covers the year ended 31 December 2020.
Anteris Technologies Ltd (ASX:AVR) (FRA:DDF) has received $1.49 million under the Australian Government’s Research and Development (R&D) Tax Incentive Scheme for the year ended 31 December 2020.
The company will now repay the short-term facility entered into with Mitchell Asset Management Pty Ltd at the end of 2020 for the advance of $1.22 million, which provided immediate funds equivalent to its forecasted R&D tax incentive offset for the majority of the 2020 calendar year.